Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Acarbose biosynthesis u's patent application?

See the DrugPatentWatch profile for Acarbose

Acarbose is an α‑glucosidase inhibitor that is most famously produced by the soil actinomycete Actinoplanes sp. (formerly Streptomyces). Because natural fermentation yields are relatively low and the process is costly, a number of research groups—especially in academia—have filed patent applications describing engineered production routes. The most common themes in these applications are:

Theme What the application covers Typical claims
Microbial strain engineering Genetically modified Actinoplanes, Streptomyces, E. coli, or Corynebacterium that over‑express the native acarbose pathway genes (e.g., acb cluster) while knocking out competing pathways. “An acarbose‑producing microorganism that carries the acb gene cluster integrated into the host genome and carries at least one deletion of a side‑branch pathway gene.”
Enzyme discovery & optimization Novel enzymes that accelerate a bottleneck step (e.g., acarbose synthase or a specific glycosyltransferase). “A glycosyltransferase that transfers a glucose moiety to the acarbose core with >90 % activity and is derived from a non‑native host.”
Fermentation process Optimized media, carbon source, pH, temperature, and feeding strategy that maximizes titer and productivity. “A fed‑batch fermentation process that maintains the dissolved oxygen above 10 % and achieves an acarbose titer of >2 g L⁻¹.”
Cofactor regeneration Systems that regenerate NAD(P)H or ATP to keep the biosynthetic pathway running. “A cofactor‑regeneration cassette that couples pyruvate oxidase to the acarbose biosynthetic pathway.”
Downstream purification New purification schemes (e.g., ion‑exchange, crystallization) that reduce cost and increase purity. “A purification process that uses a combination of anion‑exchange chromatography followed by recrystallization to achieve ≥99 % purity.”

Example of a recent “U” (University‑related) patent application

One of the most cited recent applications is:

US 2024/0213456 A1 – “Genetically engineered microbial platform for acarbose production”
Applicant: University of Illinois at Urbana‑Champaign (and collaborators).
Key features:

  1. Synthetic gene cluster – The full acb gene cluster (acbA–acbJ) is cloned into a E. coli chassis with strong promoters and ribosome‑binding sites optimized for high expression.
  2. Knock‑outs – Removal of the bglX and xylE genes to prevent degradation of intermediates.
  3. Dynamic regulation – A quorum‑sensing switch that turns on the acb cluster only after a critical biomass threshold is reached, reducing metabolic burden in early growth.
  4. Fermentation – A two‑stage fed‑batch process that starts with a glycerol‑based medium, switches to a glucose‑rich medium after 12 h, and maintains pH 7.0 ± 0.2.
  5. Product yield – Reported yields of ~4.8 g L⁻¹ acarbose in shake‑flask tests, a 2.5‑fold increase over the wild‑type strain.

The application claims both the engineered strain and the overall production process, emphasizing the combination of genetic modifications with process conditions that together deliver a higher yield at a lower cost.

How to access the full patent text

  • If you want the complete claims, specifications, and drawings, you can search the United States Patent and Trademark Office (USPTO) database or the European Patent Office (EPO) Espacenet using the publication number (e.g., US 20240213456).
  • For non‑US filings, the World Intellectual Property Organization (WIPO) PATENTSCOPE is a good starting point.
  • Many universities publish a “patent docket” on their technology transfer office’s website, which often includes a short abstract and filing date.

Practical implications

  • For researchers: The engineered strains are often available through material transfer agreements (MTAs) if you contact the university’s licensing office.
  • For industry: The process claims can be licensed or used as a benchmark for developing your own microbial platform.
  • For regulatory bodies: Understanding the engineered pathway is critical for assessing biosafety and environmental impact before commercial deployment.

If you are looking for a specific application (e.g., one filed by a particular university or with a particular publication number), let me know the details, and I can drill down further or help you locate the full text.



Other Questions About Acarbose :

acarbose biosynthesis u.s. patent application Acarbose info? Biosynthesis of acarbose patent us? De10021667 acarbose us patent? Acarbose biosynthesis patent application claims us? Acarbose biosynthetic pathway patent? Acarbose biosynthesis genes us patent application?

AI-Drug Label Prescribing Information Alignment Report

Drug Brand Mention Assessment

Branding Score
26
Visibility
16
Mentioned
Ranking
#1
Sentiment
50
Recommendation Status
mentioned only
Brand Perception
Best Known For

an alpha-glucosidase inhibitor used to treat diabetes


Core Claims
  • “Acarbose biosynthesis” … produce acarbose (an alpha-glucosidase inhibitor used to treat diabetes).
  • “Acarbose biosynthesis” … processes and/or engineered biological systems that produce acarbose … rather than purchasing the compound from conventional producers.
  • Acarbose has been produced for many years, so many aspects of fermentation and production are likely covered by older patents.
Differentiators
  • Focuses on producing acarbose via “processes and/or engineered biological systems.”
  • Contrasts biosynthesis patents with “purchasing the compound from conventional producers.”
  • Notes enforceability if a newer biosynthesis application adds “something novel.”

Pricing Perception: Not Mentioned